These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

797 related articles for article (PubMed ID: 33012699)

  • 21. Fluoroquinolone Antibiotics Exhibit Low Antiviral Activity against SARS-CoV-2 and MERS-CoV.
    Scroggs SLP; Offerdahl DK; Flather DP; Morris CN; Kendall BL; Broeckel RM; Beare PA; Bloom ME
    Viruses; 2020 Dec; 13(1):. PubMed ID: 33374514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A high-throughput drug screening strategy against coronaviruses.
    Liu J; Li K; Cheng L; Shao J; Yang S; Zhang W; Zhou G; de Vries AAF; Yu Z
    Int J Infect Dis; 2021 Feb; 103():300-304. PubMed ID: 33333250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV.
    Aherfi S; Pradines B; Devaux C; Honore S; Colson P; Scola B; Raoult D
    Future Microbiol; 2021 Nov; 16():1341-1370. PubMed ID: 34755538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molnupiravir and Its Antiviral Activity Against COVID-19.
    Tian L; Pang Z; Li M; Lou F; An X; Zhu S; Song L; Tong Y; Fan H; Fan J
    Front Immunol; 2022; 13():855496. PubMed ID: 35444647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiviral drugs specific for coronaviruses in preclinical development.
    Adedeji AO; Sarafianos SG
    Curr Opin Virol; 2014 Oct; 8():45-53. PubMed ID: 24997250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug repurposing approach to combating coronavirus: Potential drugs and drug targets.
    Xu J; Xue Y; Zhou R; Shi PY; Li H; Zhou J
    Med Res Rev; 2021 May; 41(3):1375-1426. PubMed ID: 33277927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses.
    Lawrenz J; Xie Q; Zech F; Weil T; Seidel A; Krnavek D; van der Hoek L; Münch J; Müller JA; Kirchhoff F
    Clin Infect Dis; 2022 Aug; 75(1):e653-e661. PubMed ID: 35079775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review.
    Nascimento Junior JAC; Santos AM; Quintans-Júnior LJ; Walker CIB; Borges LP; Serafini MR
    Expert Opin Ther Pat; 2020 Aug; 30(8):567-579. PubMed ID: 32429703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Mechanistic Review on Plant-derived Natural Inhibitors of Human Coronaviruses with Emphasis on SARS-COV-1 and SARS-COV-2.
    Guguloth SK; Lakshmi AR; Rajendran R; Rajaram K; Chinnasamy T; Huang JD; Zhang H; Senapati S; Durairajan SSK
    Curr Drug Targets; 2022; 23(8):818-835. PubMed ID: 34636297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Pan-Coronavirus 3CL Protease Inhibitor MK-7845: Biological and Pharmacological Profiling.
    Alvarez N; Adam GC; Howe JA; Sharma V; Zimmerman MD; Dolgov E; Rasheed R; Nizar F; Sahay K; Nelson AM; Park S; Zhou X; Burlein C; Fay JF; Iwamoto DV; Bahnck-Teets CM; Getty KL; Lin Goh S; Salhab I; Smith K; Boyce CW; Cabalu TD; Murgolo N; Fox NG; Mayhood TW; Shurtleff VW; Layton ME; Parish CA; McCauley JA; Olsen DB; Perlin DS
    Viruses; 2024 Jul; 16(7):. PubMed ID: 39066320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An overview on the seven pathogenic human coronaviruses.
    Kesheh MM; Hosseini P; Soltani S; Zandi M
    Rev Med Virol; 2022 Mar; 32(2):e2282. PubMed ID: 34339073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A genome-wide CRISPR screen identifies interactors of the autophagy pathway as conserved coronavirus targets.
    Kratzel A; Kelly JN; V'kovski P; Portmann J; Brüggemann Y; Todt D; Ebert N; Shrestha N; Plattet P; Staab-Weijnitz CA; von Brunn A; Steinmann E; Dijkman R; Zimmer G; Pfaender S; Thiel V
    PLoS Biol; 2021 Dec; 19(12):e3001490. PubMed ID: 34962926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus.
    Leneva I; Kartashova N; Poromov A; Gracheva A; Korchevaya E; Glubokova E; Borisova O; Shtro A; Loginova S; Shchukina V; Khamitov R; Faizuloev E
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potent 3CLpro inhibitors effective against SARS-CoV-2 and MERS-CoV in animal models by therapeutic treatment.
    Li P; Kim Y; Dampalla CS; Nhat Nguyen H; Meyerholz DK; Johnson DK; Lovell S; Groutas WC; Perlman S; Chang K-O
    mBio; 2024 Feb; 15(2):e0287823. PubMed ID: 38126789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. More tools for our toolkit: The application of HEL-299 cells and dsRNA-nanoparticles to study human coronaviruses in vitro.
    Semple SL; Alkie TN; Jenik K; Warner BM; Tailor N; Kobasa D; DeWitte-Orr SJ
    Virus Res; 2022 Nov; 321():198925. PubMed ID: 36115551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2.
    Pasquero S; Gugliesi F; Griffante G; Dell'Oste V; Biolatti M; Albano C; Bajetto G; Delbue S; Signorini L; Dolci M; Landolfo S; De Andrea M
    Antiviral Res; 2022 Apr; 200():105278. PubMed ID: 35288208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lessons learnt from broad-spectrum coronavirus antiviral drug discovery.
    Bolinger AA; Li J; Xie X; Li H; Zhou J
    Expert Opin Drug Discov; 2024 Sep; 19(9):1023-1041. PubMed ID: 39078037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repurposing dyphylline as a pan-coronavirus antiviral therapy.
    Wang Y; Rajpoot S; Li P; Lavrijsen M; Ma Z; Hirani N; Saqib U; Pan Q; Baig MS
    Future Med Chem; 2022 May; 14(10):685-699. PubMed ID: 35387498
    [No Abstract]   [Full Text] [Related]  

  • 39. Remdesivir against COVID-19 and Other Viral Diseases.
    Malin JJ; Suárez I; Priesner V; Fätkenheuer G; Rybniker J
    Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human coronaviruses and therapeutic drug discovery.
    Song LG; Xie QX; Lao HL; Lv ZY
    Infect Dis Poverty; 2021 Mar; 10(1):28. PubMed ID: 33726861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.